Research ArticleOriginal Article
Open Access

Potential treatment approaches for malignant peritoneal mesothelioma: in vivo and in vitro experimental study of natural killer cell immunotherapy

Heliang Wu, Yi Wang, Yulin Lin, Ru Ma, Xuemei Du, Yandong Su, Rui Yang, Zhiran Yang, Xinli Liang, Yinguang Zhang, Xiaoqing Liang, Zhonghe Ji, Chunning Lai, Yajing Huang and Yan Li
Cancer Biology & Medicine November 2024, 20240218; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0218

Article Information

20240218
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2024.0218
Published By 
Cancer Biology & Medicine
History 
  • Received June 15, 2024
  • Accepted September 27, 2024
  • Published online November 1, 2024.

Article Versions

Copyright & Usage 
Copyright: © 2024, The Authors This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License.

Author Information

  1. Heliang Wu1,2,3,
  2. Yi Wang4,
  3. Yulin Lin5,
  4. Ru Ma2,
  5. Xuemei Du6,
  6. Yandong Su2,
  7. Rui Yang2,
  8. Zhiran Yang2,
  9. Xinli Liang2,
  10. Yinguang Zhang7,
  11. Xiaoqing Liang8,
  12. Zhonghe Ji2,
  13. Chunning Lai9,
  14. Yajing Huang9 and
  15. Yan Li1,2,3⇑
  1. 1Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Peking University Ninth School of Clinical Medicine, Beijing 100038, China
  2. 2Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China
  3. 3Department of Surgical Oncology, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing 102218, China
  4. 4Department of Hematology, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100071, China
  5. 5Department of Thoracic Surgery, Zhongshan Hospital, Fudan University (Xiamen Branch), Xiamen 361015, China
  6. 6Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
  7. 7Department of Thoracic Surgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China
  8. 8Department of Oncology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China
  9. 9Innovvy Biomedical Technology Co., Ltd., Beijing 100195, China
  1. Correspondence to: Yan Li, E-mail: lya03816{at}btch.edu.cn
View Full Text

Funding

  • National Natural Science Foundation of China

    82073376

This manuscript was supported by the General Program of National Natural Science Foundation of China (Grant No. 82073376).

Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords